- Home
- CLB vs CERT Comparison
CLB vs CERT Comparison
Compare CLB & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CLB | CERT |
|---|---|---|
| Founded | 1936 | 2008 |
| Country | United States | United States |
| Employees | 3300 | N/A |
| Industry | | Retail: Computer Software & Peripheral Equipment |
| Sector | | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 864.2M | 808.9M |
| IPO Year | 2023 | 2020 |
Fundamental Metrics
Financial Performance| Metric | CLB | CERT |
|---|---|---|
| Price | $11.77 | $6.04 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 10 |
| Target Price | ★ $12.50 | $11.67 |
| AVG Volume (30 Days) | 526.0K | ★ 4.0M |
| Earning Date | 04-29-2026 | 05-11-2026 |
| Dividend Yield | ★ 0.23% | N/A |
| EPS Growth | N/A | ★ 87.50 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $526,520,000.00 | $418,838,000.00 |
| Revenue This Year | N/A | $4.18 |
| Revenue Next Year | $4.75 | $5.39 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 0.51 | ★ 8.75 |
| 52 Week Low | $9.72 | $4.45 |
| 52 Week High | $20.36 | $13.88 |
Technical Indicators
Market Signals| Indicator | CLB | CERT |
|---|---|---|
| Relative Strength Index (RSI) | 31.42 | 61.36 |
| Support Level | $11.76 | $5.93 |
| Resistance Level | $13.03 | $6.37 |
| Average True Range (ATR) | 0.55 | 0.37 |
| MACD | -0.08 | 0.08 |
| Stochastic Oscillator | 2.59 | 82.81 |
Price Performance
Historical ComparisonAbout CLB Core Laboratories Inc.
Core Laboratories Inc provides reservoir description and production enhancement services for oil and gas exploration and production. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.